YK-4-279
≥98%
- Product Code: 246221
CAS:
1037184-44-3
Molecular Weight: | Molecular Formula: | ||
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | Room temperature, dry, sealed |
Product Description:
Used in research to inhibit the interaction between the EWS-FLI1 fusion protein and RNA helicase A, which is implicated in Ewing sarcoma. Shows potential as a targeted therapy for cancers driven by ETS family transcription factors, particularly in preclinical models of Ewing sarcoma. Demonstrates anti-tumor activity by inducing apoptosis and reducing cancer cell proliferation. Also serves as a tool compound for studying oncoprotein interactions and small molecule inhibition in transcription factor-driven malignancies.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
0.010 | 10-20 days | ฿6,210.00 |
+
-
|
0.050 | 10-20 days | ฿21,360.00 |
+
-
|
0.100 | 10-20 days | ฿28,950.00 |
+
-
|
YK-4-279
Used in research to inhibit the interaction between the EWS-FLI1 fusion protein and RNA helicase A, which is implicated in Ewing sarcoma. Shows potential as a targeted therapy for cancers driven by ETS family transcription factors, particularly in preclinical models of Ewing sarcoma. Demonstrates anti-tumor activity by inducing apoptosis and reducing cancer cell proliferation. Also serves as a tool compound for studying oncoprotein interactions and small molecule inhibition in transcription factor-driven malignancies.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :